Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
If you have a question on Pfizer-BioNTech COVID19 vaccine click here.
This medicinal product does not have a marketing authorisation. It has been given authorisation for temporary supply by the relevant* National Health Regulatory Authority for active immunization against COVID-19 caused by SARS-CoV-2 in individuals within the authorized age range.
Search Medical Information*
Still Need Help?... Contact Us
Receive responses to questions through phone or email.
Call
0860 734 937
Speak live with a Pfizer Medical Information professional regarding your medical question. To report an adverse event call Pfizer at 0860 734 937 or send an email to: [email protected].
A comprehensive and timely compilation of academic journal articles on a certain therapy area.
Recent Announcements
No current announcement
Access resources for your patient’s health and general information on our products and company.